Financial Year |
March 31 2023 |
Monetary Funds |
173,053,290.06 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
9,615,649.20 |
Advances to Suppliers |
44,508,197.30 |
Other Receivables |
8,590,321.30 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
113,402,442.93 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
1,895,442.84 |
Other Current Assets |
6,722,305.76 |
Total Current Assets |
357,787,649.39 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
175,398,740.11 |
Long-term Equity Investment |
31,041,355.22 |
Investment Properties |
41,566,310.15 |
Fixed Assetes |
854,867,795.98 |
Under-construction Projects |
66,037.74 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
21,204,967.69 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
16,982,778.69 |
Deferred Income Tax Assets |
28,384,257.72 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
1,199,935,290.99 |
Total Assets |
1,557,722,940.38 |
Short-Term Loans |
207,700,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
74,190,000.00 |
Accounts Payable |
216,635,918.73 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
5,954,481.97 |
Taxes Payable |
4,416,062.46 |
Interest Payable |
-- |
Dividend Payable |
1,051,940.09 |
Other payables |
90,787,392.29 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
7,283,745.81 |
Other Current Liabilities |
6,750,788.22 |
Sub-Total of Current Liabilities |
680,572,189.72 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
25,125,767.68 |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
60,468,252.00 |
Total Liabilities |
741,040,441.72 |
Paid-In Capital(Or Share Stock) |
544,655,360.00 |
Capital Surplus |
369,857,554.53 |
Surplus Reserve |
59,137,766.29 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-156,968,182.16 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
816,682,498.66 |
Owner's Equity(Stockholder's Equity) |
816,682,498.66 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,557,722,940.38 |